This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Bristol-Myers Squibb Compnay, Celgene Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,745 
1 out of 561 
Years Active: 2025
Title: Innovations by Jennifer Griffin
Introduction
Jennifer Griffin is an accomplished inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of compounds for medical applications. Her work focuses on modulating BCL6, which has implications for treating cancer and autoimmune diseases.
Latest Patents
Jennifer Griffin holds a patent for "Modulators of BCL6 as ligand directed degraders." This patent provides compounds and compositions designed to modulate BCL6, offering potential treatments for various medical conditions, including cancer and autoimmune diseases.
Career Highlights
Throughout her career, Jennifer has worked with prominent companies in the pharmaceutical industry. She has been associated with Celgene Corporation and Bristol-Myers Squibb Company, where she has contributed her expertise in drug development and innovation.
Collaborations
Jennifer has collaborated with notable professionals in her field, including Dehua Huang and Matthew David Alexander. These collaborations have further enhanced her research and development efforts.
Conclusion
Jennifer Griffin's innovative work in biotechnology and her patent contributions highlight her role as a leading inventor in the medical field. Her efforts continue to pave the way for advancements in treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile